CID 135565976

Hy-10306

Structural Information

Molecular Formula
C21H29N5O6
SMILES
CCOC(=O)CN1CCN(CC1)C[C@@H]2CN(C(=O)O2)C3=CC=C(C=C3)C(=N)NC(=O)OC
InChI
InChI=1S/C21H29N5O6/c1-3-31-18(27)14-25-10-8-24(9-11-25)12-17-13-26(21(29)32-17)16-6-4-15(5-7-16)19(22)23-20(28)30-2/h4-7,17H,3,8-14H2,1-2H3,(H2,22,23,28)/t17-/m1/s1
InChIKey
YNBHAPKHWDNTMZ-QGZVFWFLSA-N
Compound name
ethyl 2-[4-[[(5R)-3-[4-(N-methoxycarbonylcarbamimidoyl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]piperazin-1-yl]acetate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

284
Patents

447.2118 Da
Monoisotopic Mass

1.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 448.21908 206.0
[M+Na]+ 470.20102 206.9
[M-H]- 446.20452 211.3
[M+NH4]+ 465.24562 209.7
[M+K]+ 486.17496 205.8
[M+H-H2O]+ 430.20906 194.9
[M+HCOO]- 492.21000 218.9
[M+CH3COO]- 506.22565 234.3
[M+Na-2H]- 468.18647 201.9
[M]+ 447.21125 204.5
[M]- 447.21235 204.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe